Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
8 participants
INTERVENTIONAL
2018-09-03
2019-10-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This is a single center/single unit (7-3600) exploratory study to examine the efficacy of three interventions on a subject's SOCRATES 8D score at time of discharge, at three months, and at six months. A convenience sample of all patients admitted to 7-3600 who meet the inclusion criteria for this study will be approached and provided information related to this study. Once entered into the study, the subjects will continue in the study through their hospitalizations and up to 60 days post hospitalization.
This is a quality improvement study designed specifically for the cardiac surgery population. The unit is the primary unit that subjects who are admitted with IE are located. The study's objectives include:
By date of discharge, subjects enrolled in the Peer Recovery Support Program will:
1. Actively engage in the program as defined by meeting with a Peer Support Volunteer at least two times prior to discharge, and or use of resilience journal, and or review of NA book.
2. Demonstrate negative drug screens done randomly during their hospitalization.
3. Actively contact at least one outpatient recovery program that they might enroll in prior to discharge (information about recovery programs to be provided by unit SW).
4. Demonstrate appropriate changes in their SOCRATES 8D survey scores from admission to program to post discharge.
5. Participate in follow up phone call with completion of SOCRATES 8D survey at 30 and 60 days post discharge.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The investigators do not have a total number of target subjects due to the variability of admissions with IE. The goal is to have at least 10 subjects enrolled and complete all follow ups.
1. Inclusion Criteria:
All patients considered for this program must meet the following criteria:
1. Must be at least 18 years of age and able to provide consent
2. Must speak/read/understand English
3. Currently hospitalized and physically located on 7-3600 unit
4. Followed by or on the Cardiac Surgery service
5. Have a diagnosis of Endocarditis associated with recent or remote intravenous drug use (IVDU)
6. Alert and oriented to person, place, time, and events leading up to hospitalization
7. Able to carry on a coherent conversation
8. Clinical Opiate Withdrawal (COW) score of less than or equal to 5 with no adjunctive (opioids) medication use within past 24 hours a. If COW score is greater than five or adjunctive medications have been used within the previous 24 hours, the patient will be re-evaluate every 24 hours until score is less than or equal to five and no adjunctive medications used within the previous 24 hours
2. Exclusion Criteria:
1. Under the age of 18 years old
2. Unable to speak/read/understand English
3. Hospitalized but not on 7-3600
4. Does not have a diagnosis of endocarditis associated with IVDU
5. Not followed by or on the Cardiac Surgery service
6. Not Alert or oriented or unable to carry on a coherent conversation
7. COW score that is greater than five or adjunctive medications have been used within the previous 24 hours (see inclusion criteria)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Peer Recovery Support Program
Patients enrolled in the Peer Recovery Support Program will:
1. Actively engage in the program as defined by meeting with a Peer Support Volunteer at least two times prior to discharge, and or use of resilience journal, and or review of NA book.
2. Demonstrate negative drug screens done randomly during their hospitalization.
3. Actively contact at least one outpatient recovery program that they might enroll in prior to discharge (information about recovery programs to be provided by unit SW).
4. Demonstrate appropriate changes in their SOCRATES 8D survey scores from admission to program to post discharge.
5. Participate in follow up phone call with completion of SOCRATES 8D survey at 30 and 60 days post discharge.
Peer Recovery Support Program
See above
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Peer Recovery Support Program
See above
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Must be at least 18 years of age and able to provide consent
2. Must speak/read/understand English
3. Currently hospitalized and physically located on 7-3600 unit
4. Followed by or on the Cardiac Surgery service
5. Have a diagnosis of Endocarditis associated with recent or remote intravenous drug use (IVDU)
6. Alert and oriented to person, place, time, and events leading up to hospitalization
7. Able to carry on a coherent conversation
8. Clinical Opiate Withdrawal (COW) score of less than or equal to 5 with no adjunctive (opioids) medication use within past 24 hours a. If COW score is greater than five or adjunctive medications have been used within the previous 24 hours, the patient will be re-evaluate every 24 hours until score is less than or equal to five and no adjunctive medications used within the previous 24 hours
Exclusion Criteria
2. Unable to speak/read/understand English
3. Hospitalized but not on 7-3600
4. Does not have a diagnosis of endocarditis associated with IVDU
5. Not followed by or on the Cardiac Surgery service
6. Not Alert or oriented or unable to carry on a coherent conversation
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Rochester
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
David Goede
Clinical Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David Goede, DNP ACNP-BC
Role: PRINCIPAL_INVESTIGATOR
University of Rochester School of Nursing
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Rochester Medical Center
Rochester, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SON2018-001
Identifier Type: -
Identifier Source: org_study_id
NCT03642379
Identifier Type: -
Identifier Source: nct_alias